Lose Weight.
Approved tirzepatide therapies have demonstrated weight reduction in clinical studies in appropriate patients.

A Healthier You. A Better Tomorrow.
Lose weight. Feel lighter. Rediscover your confidence and vitality.

Approved tirzepatide therapies have demonstrated weight reduction in clinical studies in appropriate patients.
GLP-1 and GIP receptor activity is involved in regulating appetite and food intake.
Weight management may be one part of a broader, individualized health and lifestyle plan.
ALUNEVIA is labeled as (tirzepatide) injection. The presentation shown here is a single-dose vial containing 10 mg / 2 mL (5 mg/mL), supplied in an outer carton.
The carton is labeled as containing one single-dose vial of 10 mg / 2 mL. Needles and syringes are not included.
The packaging states: store refrigerated at 36°F to 46°F (2°C to 8°C). Do not freeze. Protect from light. Keep out of reach of children.

The current carton contains one vial. Needles and syringes are not included.